{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T11:31:16Z","timestamp":1699961476667},"reference-count":23,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,4,11]],"date-time":"2006-04-11T00:00:00Z","timestamp":1144713600000},"content-version":"vor","delay-in-days":3297,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Dermatology"],"published-print":{"date-parts":[[1997,4]]},"abstract":"<jats:p><jats:bold>Abstract<\/jats:bold> In medicine, psoriasis and vitiligo are most often treated with PUVA therapy (psoralen plus ultraviolet A). The determination of psoralen in patients' blood is necessary, as it is admitted that the therapecutic efficiency depends on drug concentration in patients' serum. The amount of UVA to administer is inversely proportional to serum peak concentration. High performance liquid chromatography (HPLC) and gas chromatography are the most employed methods for determining psoralens in patients' serum. The 2 techniques are precise and very sensitive, but time consuming. The aim of this paper is to propose a suitable method which is rapid and simple. It is a spectrofluorimetric technique for 5\u2010methoxypsoralen (5\u2010MOP) determination in the serum of patients treated with PUVA therapy. 5\u2010MOP extraction was carried out with an heptane\/dichloromethane mixture (4\/1; v\/v), according to the Stolk method (1980). A calibration curve (CC) was plotted from 5\u2010MOP concentrations (range 50, 100, 200, 300, 400, 500 ng\/ml). The CC was linear with a good coefficient of correlation: <jats:italic>r<\/jats:italic>= 0.9971, and a suitable coefficient of variation (CV) of 7.0%. The recovery of the method ranged from 85.3\u00b14.2 to 108\u00b14.1%\/. The assay precision gave a CV ranging from 0.10 to 6.90%, with an error inferior to \u00b1 10%. The method did not reveal any interference from serum components on the 5\u2010MOP emission wavelength. The limit of detection of 5\u2010MOP was 15 ng\/ml. The proposed procedure was proved to be appropriate for a rapid determination of 5\u2010MOP in patients' serum. This technique could also be employed for other proralens used in PUVA therapy (e.g., 8\u2010methoxypsoralen.)<\/jats:p>","DOI":"10.1111\/j.1600-0625.1997.tb00147.x","type":"journal-article","created":{"date-parts":[[2006,4,11]],"date-time":"2006-04-11T17:26:03Z","timestamp":1144776363000},"page":"57-63","source":"Crossref","is-referenced-by-count":6,"title":["Spectrofluorimetric determination of 5\u2010methoxypsoralen pharmacokinetic in patients' serum"],"prefix":"10.1111","volume":"6","author":[{"given":"A.","family":"Sa\u00efd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Makki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Muret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Toubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ph.","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Millet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,4,11]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0923-1811(93)90101-T"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2340\/0001555558149151","article-title":"Plasma levels of 8\u2010methoxypsoralen and pohoto\u2010toxicity studies during PUVA treatment of psoriasis with Meladinnin tablets","volume":"58","author":"Thune P.","year":"1978","journal-title":"Acta Dermato-venereologica"},{"key":"e_1_2_1_4_2","volume-title":"Proc Int Psoralens SIR","author":"Parrish J A.","year":"1989"},{"key":"e_1_2_1_5_2","volume-title":"Proc Psoralens: past, present, and future of chemoprotection and other biological activities, SIR","author":"Makki S","year":"1989"},{"key":"e_1_2_1_6_2","unstructured":"VilchezJ L BlancR AviddR NavalonASpectrofluorimetric determination of paracetamol in pharmaceuticals and biological fluids.J Pharmaceut Biomed Anal in press."},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/00032719308017445"},{"key":"e_1_2_1_8_2","first-page":"543","article-title":"Improvement of dissolution characteristics of psoralen by cyclodextrins complexation","volume":"50","author":"Vincieri F F","year":"1995","journal-title":"II Farmaco"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1039\/an9952002401"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1021\/js950367f"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)82279-3"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02272995"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1021\/ac00024a023"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826079508010465"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/00032719508000322"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0731-7085(90)80066-X"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826079508009242"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9673(94)01212-W"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600700840"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02688481"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00455567"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1981.tb00772.x"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198611010-00004"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600650104"}],"container-title":["Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0625.1997.tb00147.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0625.1997.tb00147.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T16:59:12Z","timestamp":1698425952000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0625.1997.tb00147.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,4]]}},"alternative-id":["10.1111\/j.1600-0625.1997.tb00147.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0625.1997.tb00147.x","archive":["Portico"],"relation":{},"ISSN":["0906-6705","1600-0625"],"issn-type":[{"value":"0906-6705","type":"print"},{"value":"1600-0625","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,4]]}}}